SARL Groupe Ethique & Santé, Marseille, Provence-Alpes-Côte d'Azur, France
University Grenoble Alpes, Grenoble, France.
BMJ Open. 2024 Jul 11;14(7):e082575. doi: 10.1136/bmjopen-2023-082575.
Behavioural weight loss programmes are generally accepted as being beneficial in reducing cardiometabolic risk and improving patient-reported outcomes. However, prospective data from large real-world cohorts are scarce concerning the mid-term and long-term impact of such interventions. The objective of this large prospective cohort study (n>10 000 participants) is to demonstrate the effectiveness of the standardised Nutritional and Psycho-Behavioural Rehabilitation programme (RNPC Programme) in reducing the percentage of subjects requiring insulin and/or other diabetes drug therapy, antihypertensive drugs, lipid-lowering therapies and continuous positive airway pressure therapy for obstructive sleep apnoea after the end of the intervention. The rate of remission of hypertension, type 2 diabetes and sleep apnoea will also be prospectively assessed.
This is a prospective multicentre observational study carried out in 92 RNPC centres in France. Participants will follow the standardised RNPC Programme. The prospective dataset will include clinical, anthropometric and biochemical data, comorbidities, medications, body composition, patient-reported outcome questionnaire responses, sleep study data with objective measurements of sleep apnoea severity and surrogate markers of cardiovascular risk (ie, blood pressure and arterial stiffness). About 10 000 overweight or obese participants will be included over 2 years with a follow-up duration of up to 5 years.
Ethical approval for this study has been granted by the Ethics Committee (Comité de protection des personnes Sud-Est I) of Saint-Etienne University Hospital, France (SI number: 23.00174.000237). Results will be submitted for publication in peer-review journals, presented at conferences and inform the design of a future randomised controlled trial in the specific population identified as good responders to the RNPC Programme.
NCT05857319.
行为体重管理方案通常被认为可降低心血管代谢风险并改善患者报告的结果。然而,关于此类干预措施的中期和长期影响的大型真实世界队列的前瞻性数据仍然很少。这项大型前瞻性队列研究(超过 10000 名参与者)的目的是证明标准化营养和心理行为康复方案(RNPC 方案)在干预结束后降低需要胰岛素和/或其他糖尿病药物治疗、抗高血压药物、降脂治疗和持续气道正压通气治疗的患者比例的有效性用于阻塞性睡眠呼吸暂停。还将前瞻性评估高血压、2 型糖尿病和睡眠呼吸暂停的缓解率。
这是一项在法国 92 个 RNPC 中心进行的前瞻性多中心观察性研究。参与者将遵循标准化的 RNPC 方案。前瞻性数据集将包括临床、人体测量和生化数据、合并症、药物、身体成分、患者报告的结果问卷应答、睡眠研究数据以及睡眠呼吸暂停严重程度的客观测量和心血管风险的替代标志物(即血压和动脉僵硬)。大约 10000 名超重或肥胖参与者将在 2 年内纳入,随访时间最长可达 5 年。
该研究已获得法国圣艾蒂安大学附属医院保护人南部东部 I 伦理委员会(SI 编号:23.00174.000237)的批准。结果将提交给同行评审期刊发表,在会议上展示,并为未来在 RNPC 方案确定的良好反应者特定人群中进行的随机对照试验的设计提供信息。
NCT05857319。